Literature DB >> 17934082

Metabolic syndrome in systemic lupus erythematosus: lower prevalence in Brazil than in the USA.

George D Azevedo, Rafael G N Gadelha, Maria José Vilar.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17934082      PMCID： PMC2111624          DOI： 10.1136/ard.2007.074583

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  [Prevalence of metabolic syndrome in a semi-arid rural area in Bahia].

Authors:  Ernesto P de Oliveira; Mirabeau Levi A de Souza; Maria das Dores A de Lima
Journal:  Arq Bras Endocrinol Metabol       Date:  2006-06

3.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

4.  High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors.

Authors:  Cecilia P Chung; Ingrid Avalos; Annette Oeser; Tebeb Gebretsadik; Ayumi Shintani; Paolo Raggi; C Michael Stein
Journal:  Ann Rheum Dis       Date:  2006-08-10       Impact factor: 19.103

5.  Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors.

Authors:  Alexandre Wagner Silva de Souza; Francisca Satomi Hatta; Fausto Miranda; Emília Inoue Sato
Journal:  Sao Paulo Med J       Date:  2005-07-08       Impact factor: 1.044

6.  Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus.

Authors:  K de Leeuw; B Freire; A J Smit; H Bootsma; C G Kallenberg; M Bijl
Journal:  Lupus       Date:  2006       Impact factor: 2.911

7.  Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil).

Authors:  M J Pereira Vilar; E I Sato
Journal:  Lupus       Date:  2002       Impact factor: 2.911

8.  Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study.

Authors:  Ian N Bruce; Murray B Urowitz; Dafna D Gladman; Dominique Ibañez; George Steiner
Journal:  Arthritis Rheum       Date:  2003-11
  8 in total
  5 in total

1.  Metabolic syndrome in Iranian patients with systemic lupus erythematosus and its determinants.

Authors:  Alimohammad Fatemi; Azadeh Ghanbarian; Zahra Sayedbonakdar; Mehdi Kazemi; Abbas Smiley
Journal:  Clin Rheumatol       Date:  2018-01-05       Impact factor: 2.980

2.  Prevalence and features of metabolic syndrome in childhood-onset systemic lupus erythematosus.

Authors:  Nailú Angélica Sinicato; Mariana Postal; Karina de Oliveira Peliçari; Leticia Rittner; Roberto Marini; Simone Appenzeller
Journal:  Clin Rheumatol       Date:  2017-04-19       Impact factor: 2.980

3.  Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age.

Authors:  Marta Maria das Chagas Medeiros; Ídila Mont'Alverne Xavier de Oliveira; Ádilla Thaysa Mendes Ribeiro
Journal:  Rheumatol Int       Date:  2015-07-07       Impact factor: 2.631

4.  Metabolic syndrome in lupus patients in northeast of Iran, and their lifestyle habits.

Authors:  Mohammad Reza Hatef-Fard; Mina Khodabandeh; Maryam Sahebari; Majid Ghayour-Mobarhan; Zahra Rezaieyazdi
Journal:  Caspian J Intern Med       Date:  2016

5.  The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus.

Authors:  Domenico Paolo Emanuele Margiotta; Fabio Basta; Giulio Dolcini; Veronica Batani; Luca Navarini; Antonella Afeltra
Journal:  PLoS One       Date:  2017-11-07       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.